Cyclacel Pharmaceuticals Inc CYCCP:NASDAQ

RT Quote | NASDAQ | USD
Last | 02/26/21 EST
7.45UNCH (UNCH)
52 week range
4.81 - 9.35

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.45
  • 52 Week High9.35
  • 52 Week High Date01/05/21
  • 52 Week Low4.81
  • 52 Week Low Date07/24/20
  • Market Cap33.56M
  • Shares Out4.86M
  • 10 Day Average Volume0.00M
  • Dividend0.60
  • Dividend Yield8.05%
  • Beta
  • 1 Year % Change21.14

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date01/14/2021
  • Div Amount0.15
  • Split Date-
  • Split Factor-

Latest Cyclacel Pharmaceuticals Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Cyclacel Pharmaceuticals, Inc. operates in the field of cell cycle biology. The Company has generated various families of anticancer drugs that act on the cell cycle, including nucleoside analogs, cyclin dependent kinase (CDK) inhibitors, polo-like kinase (PLK) inhibitors and Aurora Kinase/vascular endothelial growth factor receptor (AK/VEGFR) inhibitors. Its family of anticancer drugs that act on the cell cycle include sapacitabine, seliciclib and CYC065. Its lead candidate...
David U'Prichard Ph.D.
Chairman
Christopher Henney Ph.D.
Vice Chairman
Spiro Rombotis
President
Paul McBarron
Chief Financial Officer
Judy Chiao M.D.
Vice President
Address
200 Connell Dr Ste 1500
Berkeley Heights, NJ
07922-2811
United States